Moderna | MRNA - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
Acadia Pharmaceuticals USD 46.47M 42.49M 2026-06
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Alnylam Pharmaceuticals USD 177.81M 43.85M 2026-06
Amgen USD 2.08B 570M 2026-03
Arrowhead Research USD -178.9M 41.34M 2026-06
Biogen USD 647.3M 269.6M 2026-06
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Celltrion KRW 11.84B 1.34B 2026-03
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 11.8B 2.17B 2026-06
Gilead Sciences USD -7.53B 10.11B 2026-06
GlaxoSmithKline GBP 2.68B 532M 2026-06
Incyte USD 751.51M 407.91M 2026-06
Ionis Pharmaceuticals USD -114M 21M 2026-06
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Moderna USD -1.33B 535M 2026-03
Organigram Holdings CAD -921K 40.8M 2026-03
Pharma Mar EUR -993K 2.59M 2026-06
Puma Biotechnology USD 20.61M 24.76M 2024-09
Qiagen NV USD 157.9M 72.08M 2026-06
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
Sartorius EUR 127M 30.8M 2026-06
Tilray USD -39.96M 39.19M 2025-09
Ultragenyx Pharmaceutical USD -91M 93M 2026-06
United Therapeutics USD 372.7M 54.4M 2026-06
Vertex Pharmaceuticals USD 1.39B 138.9M 2026-06
Zealand Pharma A/S -394M 12.5M 2026-03
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03